• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与二丁基方形酸酯局部致敏相关的临床后遗症。

Clinical sequelae associated with squaric acid dibutylester topical sensitization.

作者信息

Foley S, Blattel S A, Martin A G

机构信息

Division of Dermatology, Washington University School of Medicine, St Louis, MO 63110, USA.

出版信息

Am J Contact Dermat. 1996 Jun;7(2):104-8.

PMID:8796751
Abstract

BACKGROUND

Squaric acid dibutylester (SADBE) is a potent topical sensitizer used in the treatment of various cutaneous conditions. Currently, there are no standardized protocols defining safe sensitization methods or treatment regimens following sensitization.

OBJECTIVE

This is a literature review of the clinical use of SADBE and a report of our experience with SADBE therapy and its potential hazards.

METHODS

SADBE was applied with a cotton swab to the forearm of 14 patients to induce contact dermatitis.

RESULTS

Ten of 14 patients (71%) had severe eczematous reactions at the site of sensitization, and 9 of 14 (64%) developed disseminated reactions.

CONCLUSION

Standard protocols delineating safe methods of sensitization and treatment with SADBE need further development.

摘要

背景

二丁基 Squaric 酸酯(SADBE)是一种强效外用致敏剂,用于治疗各种皮肤疾病。目前,尚无标准化方案来定义安全的致敏方法或致敏后的治疗方案。

目的

这是一篇关于 SADBE 临床应用的文献综述,并报告我们使用 SADBE 治疗的经验及其潜在危害。

方法

用棉签将 SADBE 涂抹于 14 名患者的前臂以诱发接触性皮炎。

结果

14 名患者中有 10 名(71%)在致敏部位出现严重湿疹样反应,14 名中有 9 名(64%)出现播散性反应。

结论

需要进一步制定描述 SADBE 安全致敏方法和治疗方法的标准化方案。

相似文献

1
Clinical sequelae associated with squaric acid dibutylester topical sensitization.与二丁基方形酸酯局部致敏相关的临床后遗症。
Am J Contact Dermat. 1996 Jun;7(2):104-8.
2
Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts.用二丁基酒石酸酯进行接触免疫疗法治疗顽固性疣。
J Am Acad Dermatol. 1999 Oct;41(4):595-9.
3
Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
Contact Dermatitis. 2000 Jul;43(1):52-3.
4
Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.一名斑秃患者使用二丁基酒石酸酯进行局部免疫治疗引发接触性皮炎,进而加重盘状红斑狼疮。
J Dermatol. 2008 Mar;35(3):151-3. doi: 10.1111/j.1346-8138.2008.00435.x.
5
An answer to some questions raised by skin reactions observed during squaric acid dibutylester contact sensitization.对丁二酸二丁酯接触致敏过程中观察到的皮肤反应所引发的一些问题的解答。
Contact Dermatitis. 2001 Sep;45(3):189-90. doi: 10.1034/j.1600-0536.2001.045003189.x.
6
Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group.斑贴试验制剂对苯二胺和环氧树脂的迟发性反应:德国接触性皮炎研究组的一项前瞻性多中心研究
Br J Dermatol. 2006 Apr;154(4):665-70. doi: 10.1111/j.1365-2133.2006.07159.x.
7
[Immunotherapy of multiple recurring warts. II. Reassessment of the use of squaric acid dibutylester (SADBE) (author's transl)].[多发性复发性疣的免疫疗法。II. 二丁基方形酸酯(SADBE)使用的重新评估(作者译)]
Ann Dermatol Venereol. 1981;108(10):765-7.
8
[Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].斑秃局部免疫治疗过程中的色素沉着异常
G Ital Dermatol Venereol. 1989 Jan-Feb;124(1-2):31-2.
9
Textile dermatitis in patients with contact sensitization in Israel: a 4-year prospective study.以色列接触致敏患者的纺织性皮炎:一项为期4年的前瞻性研究。
J Eur Acad Dermatol Venereol. 2004 Sep;18(5):531-7. doi: 10.1111/j.1468-3083.2004.00967.x.
10
Squaric acid sensitization is not required for response in the treatment of alopecia areata.曲酸敏化对于斑秃治疗中的反应不是必需的。
J Am Acad Dermatol. 2015 Sep;73(3):471-6. doi: 10.1016/j.jaad.2015.04.064.

引用本文的文献

1
Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.接触免疫疗法在斑秃以外的皮肤病治疗中的应用。
Dermatol Ther (Heidelb). 2022 Nov;12(11):2415-2452. doi: 10.1007/s13555-022-00818-7. Epub 2022 Sep 22.